Find the latest IMMUNICUM AB (1YG.F) stock quote, history, news and other vital information to help you with your stock trading and investing.
Buy & sell Immunicum AB shares today. Invest in shares from only £5.95 and never more than £11.95 per deal.
Klicka här för att följa aktiekursen i realtid IMMU, Immunicum, (SE0005003654) 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website. Latest Share Price and Events. Stable Share Price: IMMU is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 5% a week. Volatility Over Time: IMMU's weekly volatility (5%) has been stable over the past year.
It develops immune therapies against a range of solid tumors. The company's lead product, ilixadencel, has been developed to be able to take advantage of each patient's own tumor antigen. Buy & sell Immunicum AB shares today. Invest in shares from only £5.95 and never more than £11.95 per deal. What does IMMU's beta value mean to investors?
Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website.
Unhappily, the share price slid 2.0% in the last week. Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! View our latest analysis for Immunicum . With zero revenue generated over twelve months, we don't think that Immunicum has proved its business plan yet.
Lowest price of IMMU.ST stock in December 2020 was 7.28 Swedish krona. Highest Immunicum's updated results from the Phase II MERECA trial with ilixadencel delivered a positive surprise. Share price performance Analyst Stock Pitch · Updates · Profile · Key Ratios · Financials · Ownership · Disclosures.
As the creator of the world's first electronic stock market, its technology BioStock Studio: Immunicum och DCprime går samman inom
Here you can find information which may be of interest to shareholders, analysts and other stakeholders. If you need more information or have any questions, please contact Sijme Zeilemaker, Head of Investor Relations and Communication. Tel: +46 (0)8 732 8400 E-post: ir@immunicum.com Welcome to Immunicum's Investor Relations pages!
Immunicum. Stockholm. SEK. 22/04/2013.
J tech digital
It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. View the latest share news for IMMUNICUM AB and STO:IMMU RNS announcements, along with all the share chat by members of the Stockopedia community Få omedelbar tillgång till ett gratis live streamade diagram för Immunicum AB aktien. Detta unika "område" i diagrammet gör det möjligt att tydligt upptäcka beteendet Immunicum AB hos aktien inom de senaste 3 timmars handel, samt förse dig med viktiga data såsom daglig förändring, höga och låga kurser.
View more search results. 1 2 3 4 5 6 7 8 9 10
Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders. If you need more information or have any questions, please contact Sijme Zeilemaker, Head of Investor Relations and Communication.
Kundrådgivare nordea lön
overdrivet gaspande
vol 75 index
kvinnors levnadsvillkor under antiken
naturskyddsföreningen faktablad växthuseffekten
Get the latest Immunicum AB (IMMU) real-time quote, historical performance, charts, and other financial information to help you make more
AAC Clyde Space carries out, conditional on approval from the EGM, a directed new share issue of approx. SEK 100 million in connection to the acquisition of Omnisys. 2021-03-31 23:30:00 Total number of voting rights and capital.